Table 1.

Clinical characteristics of patients and healthy subjects.

Features	PFBS (n=23)	NHF (n=27)	P value
Gender	Male:21, Female:2	Male:15, Female:12	0.013*
Age	65.17 ± 5.39	62.22 ± 7.41	0.119
Smoking	Yes:18, No:5	Yes:11, No:16	0.007*
Drinking	Yes:20, No:3	Yes:10, No:17	0.001*
TC	4.11 ± 1.01	4.41 ± 0.71	0.224
TG	0.92 ± 0.34	0.81 ± 0.48	0.336
HDL-C	1.15(0.94,1.30)	1.27(1.14,1.43)	0.018*
LDL-C	2.40 ± 0.81	2.74 ± 0.79	0.143
VLDL-C	0.22(0.16,0.29)	0.21(0.16,0.27)	0.579
Lp (a)	325.70 ± 224.59	145.74 ± 90.10	0.001*
ApoA-I	1.07 ± 0.15	1.51 ± 0.30	<0.001*
ApoE	39.82 ± 13.83	39.99 ± 5.92	0.956
ApoB	0.83 ± 0.27	0.92 ± 0.20	0.189
FFA	0.50(0.44,0.60)	0.54(0.36,0.72)	0.392
WBC	7.83 ± 2.43	6.47 ± 1.66	0.03*
FBG	6.31(5.44,7.99)	4.96(4.38,5.49)	<0.001*
TyG	5.93(4.03,7.81)	4.03(1.71,6.14)	0.01*
N	4.78(3.41,7.70)	3.99(2.66,5.07)	0.019*
L	1.58 ± 0.54	2.04 ± 0.59	0.006*
NLR	3.12(2.44,5.57)	2.04(1.24,2.38)	0.001*
SUA	273.00(250.00,356.00)	213.00(143.00,297.00)	0.05*

* denotes statistically significant differences as determined by Student’s T-test or Wilcoxon rank-sum test.